The Verge·Apr 30, 2026

🧬Colossal Raises Millions for De-Extinction Projects

Is Bringing Back Extinct Species Worth It?

TL;DR

Colossal, a biotech startup, has raised hundreds of millions to bring back extinct species like the woolly mammoth and bluebuck. Critics argue it distracts from saving endangered animals.

Colossal, backed by major investors including Peter Thiel, has secured over $100 million for its ambitious de-extinction projects aimed at reviving lost species such as the woolly mammoth and bluebuck. The company's novel ovum pickup technique allows them to collect genetic material from live animals, which could be used in conservation efforts. However, critics like ecologist Douglas McCauley argue that focusing on extinct species diverts attention from critically endangered ones still in need of help.

Colossal Raises Millions for De-Extinction Projects

Key Points

1

Colossal has raised hundreds of millions, including CIA and Peter Thiel funding.

2

Projects aim to revive extinct animals like the woolly mammoth and bluebuck.

3

Ovum pickup technique harvests immature egg cells for genetic preservation.

4

Critics argue focus on de-extinction pulls attention from endangered species.

5

Colossal's techniques will be available for conservation efforts outside the company.

Why It Matters

If you're involved in wildlife conservation, Colossal's $100M+ raise could shift priorities. Their ovum pickup technique can aid existing at-risk species but critics argue it distracts from urgent needs.

de-extinctionconservationventure-capital

Frequently Asked Questions

Why does this matter?

If you're involved in wildlife conservation, Colossal's $100M+ raise could shift priorities. Their ovum pickup technique can aid existing at-risk species but critics argue it distracts from urgent needs.

What happened?

Colossal, a biotech startup, has raised hundreds of millions to bring back extinct species like the woolly mammoth and bluebuck. Critics argue it distracts from saving endangered animals.

Comments

Subscribe to join the conversation...

Be the first to comment

Enjoyed this article?

Get it daily. 7am. Free. Reads in 5 minutes.